ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo

To overcome the harmful side effects, low tolerance, and undesirable outcomes of the anticancer drugs, we used ethane-1,2-diamine to bridge antitumoral (S)-3-acetyl-4-oxo-tetrahydroindolo[2,3-a]quinolizine-6-carboxylic acid (ATIQC) and tumor-targeting d-glucuronic acid, thereby providing (6S)-3-acet...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Nanomedicine
Hlavní autoři: Xu, Xinyi, Wang, Yuji, Wu, Jianhui, Hu, Xi, Zhu, Haimei, Zhang, Xiaoyi, Wang, Yaonan, Gui, Lin, Zhao, Ming, Peng, Shiqi
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5476604/
https://ncbi.nlm.nih.gov/pubmed/28652742
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S129989
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky